This Biotech Startup Raised $34 Million For Urine-Based Tests To Help Diagnose Cancer

With rising cancer rates necessitating new forms of diagnosis and treatment, Hong Kong-based biotech startup Phase Scientific International announced Tuesday it raised $34 million in a Series A funding round led by Asian asset management firm Value Partners Group.

Under a private equity fund of Value Partners, which was cofounded by billionaire Cheah Cheng Hye, the Series A brought Phase Scientific’s…